Virtus Investment Advisers’s ACELYRIN SLRN Stock Holding History

Virtus Investment Advisers’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-46,372	Closed	-$115K	–	490
2025 Q1	$115K	Buy	46,372 +10,672	+30%	+$25.4K	0.03%	400
2024 Q4	$112K	Hold	35,700	–	–	0.09%	251
2024 Q3	$176K	Buy	+35,700	New	+$184K	0.14%	212

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Virtus Investment Advisers's SLRN Position: Q2 2025 in Review

Virtus Investment Advisers sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 46,372 shares — an estimated $115K sold.

Virtus Investment Advisers first reported a position in SLRN in Q3 2024 and held it in 3 quarters. The position peaked at $176K in Q3 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Virtus Investment Advisers reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Virtus Investment Advisers sold 46,372 ACELYRIN shares in Q2 2025, an estimated $115K.
Virtus Investment Advisers first reported a position in ACELYRIN in Q3 2024 and held it in 3 quarters.
Virtus Investment Advisers's ACELYRIN position peaked at $176K in Q3 2024.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Virtus Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.